GENMAB AS SP.ADR/1/10DK 1 (GE91) — Working Capital to Net Assets Ratio
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Working Capital to Net Assets ratio of 24.9% as of December 2025. Working capital of €1.46 Billion (current assets of €2.88 Billion minus current liabilities of €1.43 Billion) is measured against net assets of €5.85 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GE91 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GENMAB AS SP.ADR/1/10DK 1 Working Capital to Net Assets (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 24.9%, reflecting working capital of €1.46 Billion against net assets of €5.85 Billion EUR. For the complete balance sheet picture, see GENMAB AS SP.ADR/1/10DK 1 (GE91) total assets.
Annual Working Capital to Net Assets for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of GENMAB AS SP.ADR/1/10DK 1 to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.9% | €1.46 Billion | €5.85 Billion | €2.88 Billion | €1.43 Billion | ▼ -36.5 pp |
| 2024 | 61.4% | €3.15 Billion | €5.12 Billion | €3.89 Billion | €740.55 Million | ▼ -35.5 pp |
| 2023 | 97.0% | €4.55 Billion | €4.69 Billion | €4.92 Billion | €368.80 Million | ▲ +0.2 pp |
| 2022 | 96.7% | €3.80 Billion | €3.93 Billion | €4.06 Billion | €262.38 Million | ▲ +1.4 pp |
| 2021 | 95.4% | €3.22 Billion | €3.38 Billion | €3.46 Billion | €238.71 Million | — |